| eInvest Better Future (Managed Fund) (IMPQ) |
Financials |
$37 |
IMPQ Monthly Portfolio Disclosure
|
30 Jan 2026 10:34AM |
$4.860 |
$4.690 |
fallen by
3.50%
|
|
| C29 Metals Limited (C29) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:34AM |
$0.030 |
$0.039 |
risen by
30%
|
|
C29 - Price-sensitive ASX Announcement
Full Release
Key Points
- Focused on administrative tasks and planning for Sampsons Tank Copper project.
- Exploring new acquisition opportunities globally.
- Ended the quarter with $211,000 cash.
- Entered a $150,000 convertible loan agreement with a director.
- Plans to raise further capital based on past success.
- Payments to related parties totaled $136,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVA Risk Group Limited (AVA) ORDINARY FULLY PAID |
Information Technology |
$15 |
Cleansing Notice
|
30 Jan 2026 10:34AM |
$0.065 |
$0.053 |
fallen by
18.46%
|
|
AVA - Price-sensitive ASX Announcement
Full Release
Key Points
- AVA Risk Group Limited issued a Cleansing Notice under section 708A of the Corporations Act.
- The Cleansing Notice pertains to the issuance of Tranche 1 Notes and Tranche 1 Warrants.
- AVA entered into a Convertible Note Facility and Warrant Deed with Hale Capital Management.
- The initial drawdown of $2,979,184 was completed with Hale subscribing to 2,979,184 convertible notes.
- The conversion price for the notes is set at $0.1234 per share.
- AVA also issued 19,314,000 unlisted warrants exercisable at the same price for five years.
- A further potential funding of $4,020,816 through Tranche 2 Notes is subject to shareholder approval.
- The funding aims to support AVA’s working capital and growth initiatives in the US market.
- The conversion or exercise of these securities may significantly affect AVA’s capital structure.
- Conditions including shareholder approval are necessary for the Tranche 2 issuance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PEXA Group Limited (PXA) ORDINARY FULLY PAID |
Real Estate |
$2,660 |
Revised Timeline for IPART ELNO Fee review
|
30 Jan 2026 10:34AM |
$13.800 |
$14.980 |
risen by
8.55%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$15 |
OncoSil delivers strong early clinical results in Turkiye
|
30 Jan 2026 10:32AM |
$0.800 |
$0.650 |
fallen by
18.75%
|
|
| Cobalt Blue Holdings Limited (COB) ORDINARY FULLY PAID |
Materials |
$44 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:32AM |
$0.083 |
$0.076 |
fallen by
8.43%
|
|
COB - Price-sensitive ASX Announcement
Full Release
Key Points
- COB received a $1.2 million ATO Research and Development rebate.
- The company raised $5.3 million through an oversubscribed placement.
- Cobalt Blue is progressing towards a final investment decision for the Kwinana Cobalt Refinery.
- The Broken Hill Technology Centre is focusing on evaluating battery black mass as a potential feedstock.
- COB's cash position increased to $6.72 million by the end of the quarter.
- The company reduced staff salaries by 25% to 30% temporarily to preserve cash.
- Cobalt Blue aims to integrate recycled battery material into its business plan.
- COB confirmed no significant changes in its tenement holdings during the quarter.
- The company is engaging with potential offtake partners and exploring further financing options.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Legacy Minerals Holdings Limited (LGM) ORDINARY FULLY PAID |
Materials |
$41 |
Application for quotation of securities - LGM
|
30 Jan 2026 10:32AM |
$0.215 |
$0.205 |
fallen by
4.65%
|
|
| Omnia Metals Group Limited (OM1) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:31AM |
$0.025 |
$0.025 |
fallen by
0%
|
|
OM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed first-pass SLRC drilling at Salt Creek Project.
- Drilling provided key geological and geochemical data.
- Successfully completed $1.58 million placement.
- Company focuses on securing antimony, silver, and REE projects.
- Net cash increase to $1.708 million.
- No significant mineralization found at Salt Creek.
- Estimated funding available for over five quarters.
- Exploration in Western Australia and potential U.S. acquisitions.
- Continued strategic positioning through partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$31 |
Trading Halt
|
30 Jan 2026 10:31AM |
$0.024 |
$0.016 |
fallen by
33.33%
|
|
AGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aguia Resources Limited requests a trading halt on its securities.
- The halt is pending a fund raising announcement.
- The trading halt will last until the announcement is released or by 3 February 2026.
- ASX Listing Rule 17.1 has been referenced for the trading halt.
- Company Secretary Ross Pearson signed the request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$15 |
Q2 FY26 Activities Report and Appendix 4C
|
30 Jan 2026 10:27AM |
$0.100 |
$0.110 |
risen by
10%
|
|
RNV - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly sales increased by 80% compared to the corresponding quarter in FY25.
- ReNerve Limited completed a capital raise, securing $2.6 million in financing.
- The company achieved hospital approvals for the NervAlign® Nerve Cuff in the US Department of Defence and Veterans Affairs hospital network.
- ReNerve launched its Empliq product ranges, including human tissue products.
- The company continues to focus on product development, aiming for NervAlign® Nerve Conduit market entry in 1H CY2026.
- The quarterly cash flow report showed closing cash of $4.18 million.
- ReNerve is advancing a complete suite of nerve repair solutions, including the NervAlign® Nerve Cuff and Nerve Conduit Range.
- The company anticipates strong growth and is focused on securing approval for products in additional markets, including India and Europe.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,289 |
University of Chicago Medicine adopts CTVQ
|
30 Jan 2026 10:25AM |
$3.430 |
$4.000 |
risen by
16.62%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- University of Chicago Medicine expands agreement with 4DMedical to include CT:VQ™.
- UChicago becomes the fifth U.S. academic medical center to adopt CT:VQ™.
- The partnership includes a commercial contract and prepaid CT:VQ™ scan package.
- CT:VQ™ is used for complex lung disease assessment and procedural planning.
- Professor Kyle Hogarth highlights CT:VQ™'s clinical advantages at UChicago.
- CT:VQ™ has been deployed at leading academic centers within five months of FDA clearance.
- 4DMedical is a leader in respiratory imaging technology, utilizing advanced imaging and AI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 10:25AM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- North American market strategy launched through a Canadian distribution agreement.
- Began national retail distribution with Rebel in Australia.
- PROTEQT© included in an Australian Research Council-funded research program.
- Raised approximately $925,000 through an oversubscribed placement.
- Cash reserves of $359,670 reported at the end of the quarter.
- Exclusive partnership with Sportscover for insurance integration.
- Focus on expanding market reach and consolidating research validation into commercial contracts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AuMEGA Metals Ltd (AAM) ORDINARY FULLY PAID |
Materials |
$32 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:23AM |
$0.039 |
$0.041 |
risen by
5.13%
|
|
AAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Isle aux Morts Granite advanced as top priority target with large geochemical footprint.
- Bunker Hill target portfolio upgraded with new gold and base metals corridors.
- Diamond drilling completed on electromagnetic anomaly at Cape Ray.
- Hermitage geochemical program completed, assays pending.
- Net cash outflow for the quarter from operating, investing, and financing activities.
- Decrease in cash and cash equivalents by the end of December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$170 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:23AM |
$0.097 |
$0.155 |
risen by
59.79%
|
|
GBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Side Well resource updated to 16.0Mt @ 2.0g/t Au for 1.02 million ounces.
- Chris Tuckwell appointed as Non-Executive Chairman.
- High-grade gold intersections announced at Eaglehawk and Mulga Bill.
- Over 34,000m of drilling completed at Side Well during December quarter.
- Cash balance at end of December 2025 was $12.0 million, increasing to $15.3 million post January due to option exercises.
- Focus on mining approvals at Ironbark and resource growth at Side Well.
- Total available funding estimated to cover approximately 3 quarters of operations.
- Great Boulder Resources holds interests in multiple projects and tenements in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$8 |
Supplementary Prospectus
|
30 Jan 2026 10:22AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| IPB Petroleum Limited (IPB) ORDINARY FULLY PAID |
Energy |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:18AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
IPB - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed Binding Terms Sheet to acquire Peritas LLC's Alaskan leases.
- Raised approximately $1.27 million for studies and acquisitions.
- Plans to change company name to Forte Energy Limited.
- End of quarter cash balance at $1.84 million.
- Focus on securing partners for drilling commitments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$25 |
Final Director's Interest Notice - P Heick
|
30 Jan 2026 10:18AM |
$0.145 |
$0.335 |
risen by
131.03%
|
|
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,289 |
Quarterly Activity Report and Appendix 4C
|
30 Jan 2026 10:17AM |
$3.410 |
$4.000 |
risen by
17.30%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic appointment of Julian Sutton as Chief Financial Officer.
- 31% increase in SaaS revenue in H1 FY26.
- Significant cost optimization achieved.
- Rapid commercial adoption of CT:VQ™.
- Successful $150 million institutional placement.
- FDA and Health Canada clearances boost market potential.
- Strong operational momentum with increased scan production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$161 |
December 2025 Quarterly Report
|
30 Jan 2026 10:17AM |
$0.665 |
$0.670 |
risen by
0.75%
|
|
BRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Full-year EBITDA guidance maintained at $35m-$45m.
- Half-year consolidated EBITDA amounted to $16m.
- Buller Plateaux Continuation Project nearing Fast Track Approvals.
- Tenas Project progressing with regulatory approvals in British Columbia.
- Export segment sales increased, but pricing and product mix affected earnings.
- Adverse weather impacted production and overburden removal.
- Hard Coking Coal price volatility influenced financial outcomes.
- Health and safety improvements through revised injury management standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$25 |
Final Director's Interest Notice - W Sauer
|
30 Jan 2026 10:16AM |
$0.145 |
$0.335 |
risen by
131.03%
|
|
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 10:16AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- First-ever free cash flow positive quarter for Cann Group Limited.
- Debt restructuring reduced debt from $70.4M to $14.8M.
- Capital raise completed with $9.0M raised before costs.
- Received $1.8M R&D Tax Refund, net receipt of $0.3M after loan repayment.
- Quarterly revenue decreased to $1.6M with a YTD of $4.5M.
- Payments to suppliers reduced by 32% compared to the previous corresponding period.
- Entered export partnering discussions with purchase orders received.
- Launched new products including Lazer Fuel, gaining market momentum.
- Completed debt restructure with NAB, extinguished remaining liabilities.
- Expanded Botanitech product portfolio with new SKU launches.
- Uplift in demand for premium Lazer Fuel cultivar observed.
- Reviewed commercial strategy to prioritize high-performing sales channels.
- Invested in long-term customer relationships and optimized vendor costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$4,483 |
Change of person responsible for communication with ASX
|
30 Jan 2026 10:16AM |
$27.780 |
$24.570 |
fallen by
11.56%
|
|
| Duratec Limited (DUR) ORDINARY FULLY PAID |
Industrials |
$541 |
DURATEC 1H FY26 RESULTS WEBINAR
|
30 Jan 2026 10:15AM |
$2.250 |
$2.100 |
fallen by
6.67%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 10:15AM |
$0.076 |
$0.079 |
risen by
3.95%
|
|
T92 - Price-sensitive ASX Announcement
Full Release
Key Points
- Terra Critical Minerals Limited focuses on tin, tungsten, molybdenum, bismuth, silver, and gold in NSW.
- Core projects include the Ottery Tin Mine and Glen Eden Project.
- In Canada, the company is active in the Athabasca Basin for uranium exploration.
- Cash balance at the end of the quarter was A$0.239 million.
- Net cash outflow from operating activities was A$0.290 million.
- Uranium projects in Canada aim to benefit from growing demand for clean energy.
- The report includes Appendix 5B cash flow report detailing financial activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$10 |
Quarterly Activities and Cashflow Report - December 2025
|
30 Jan 2026 10:14AM |
$0.042 |
$0.052 |
risen by
23.81%
|
|
DUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Dundas Minerals Limited acquired 80% interest in the Romano Project.
- The Romano Project is a major land holding of 800 km² within the Yamarna-Dorothy Hills shear system.
- Capital placement raised $1.1 million to support gold projects and new opportunities.
- Appointment of Jonathan Downes as Managing Director.
- Exploration and planning activities are ongoing at the Gerry Well and Kalgoorlie Gold Projects.
- The Gerry Well Project utilises advanced AI targeting techniques for exploration.
- Dundas completed a share placement raising gross proceeds of $1,120,000.
- The company's cash flow from operating activities was negative, showing a net usage.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
